Back To Search Results

Buphthalmos

Editor: Bhupendra C. Patel Updated: 1/20/2025 12:22:21 AM

Introduction

The clinical term "buphthalmos" describes the visible enlargement of the eyeball, typically detected at birth or shortly after, due to uncontrolled glaucoma in early childhood. The name originates from the Greek word meaning "ox-eyed." Congenital eye enlargement was noted as early as 400 BC by Hippocrates and later by Celsus and Galen in the 1st and 2nd centuries AD. However, the condition was not initially associated with increased intraocular pressure (IOP). This connection was established after the 19th century with the advent of the ophthalmoscope and tonometer, as well as advancements in anatomical dissection.

Buphthalmic eyes typically have corneal diameters exceeding 12 mm in newborns or 13 mm in children older than 1 year (see Image. Buphthalmos). The diameters sometimes exceed 16 mm, with the globe appearing noticeably enlarged. Normal corneal diameters are 9.5 to 10.5 mm at birth and 11 to 12 mm by age 1.[1]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

IOP elevation stretches the cornea and sclera, causing buphthalmos. The condition arises most frequently from primary congenital glaucoma, where abnormal development of the anterior chamber angle leads to impairment of aqueous humor drainage.[2] Mutations in the CYP1B1 and PAX6 genes are also associated with IOP elevation.[3][4] Other secondary conditions that can raise IOP include Sturge-Weber syndrome, neurofibromatosis, and aniridia.[5][6][7]

Epidemiology

The average prevalence of buphthalmos is around 1 in 30,000 births.[8] The Slovak Romani, South Indian, and Saudi Arabian populations show a significantly higher prevalence of primary congenital glaucoma than the rest of the world. In Saudi Arabia and the Romani population of Slovakia, primary congenital glaucoma is the most frequent cause of childhood blindness. The highest reported prevalence is in Slovakia, with 1 in 1,250 live births, followed by Saudi Arabia, with 1 in 2,500 live births.[9]

Pathophysiology

Extensive growth of the human eye occurs in the first 5 years of life, with the greatest increase in axial length seen in the first 4 years. High IOP increases axial length and corneal diameter. This increase in the size of the eyeball in congenital glaucoma occurs due to the extreme softness and elasticity of the infantile eyeball.

Eyeball enlargement can cause axial myopia, while an increase in corneal diameter can cause corneal thinning and breaks in the Descemet membrane, called "Haab striae," a classical finding in patients with buphthalmos. The number of endothelial cells in the cornea is often reduced, leading to corneal haziness. The severity of corneal haze correlates with increases in the IOP, cup-to-disc ratio, and corneal diameter.[10]

History and Physical

The most common causes of buphthalmos are primary congenital glaucoma, which presents at birth, and primary infantile glaucoma, which develops after birth and up to the age of 3 years. Buphthalmos is typically absent in glaucoma that begins after the age of 3 years, making juvenile-onset glaucoma, occurring from 3 years to adolescence, unassociated with buphthalmos.[11]

The classic symptoms of congenital and infantile glaucomas include tearing, photophobia, and irritability (see Image. Buphthalmos with Bilateral Tearing and Light Sensitivity). Parents may observe corneal haziness or enlargement. Clinicians may identify an increased corneal diameter, a deep anterior chamber, and an enlarged globe during examination. The corneal examination may reveal edema and Descemet membrane rupture (Haab striae). IOP elevation is a hallmark feature. Optic disc cupping may also be present.

Several other conditions can lead to buphthalmos. Aniridia, an autosomal dominant disorder, is characterized by complete or partial iris hypoplasia. Glaucoma in aniridia is believed to result from angle closure. Neurofibromatosis type 1, another autosomal dominant condition, presents with multiple neurofibromas, café au lait spots, iris Lisch nodules, and axillary or inguinal freckling. Glaucoma in this condition is associated with developmental anomalies of the anterior chamber angle. Sturge-Weber syndrome, which includes nevus flammeus of the face and meningeal angiomas, is linked to glaucoma in approximately 60% of cases. The glaucoma in individuals with this condition is attributed to angle developmental anomalies and raised episcleral venous pressure.[12]

Evaluation

The evaluation of buphthalmos typically involves an examination under anesthesia. Key assessments include refraction using streak retinoscopy and a detailed evaluation of the cornea. Measurement of the corneal diameter using calipers is an essential step, as a diameter greater than 12 mm is considered abnormal. Corneal edema, often resulting from elevated IOP, may also be observed. Haab striae, which are horizontal or parallel to the limbus, may be identified during the examination.[13]

The anterior segment should be examined for other potential underlying causes of buphthalmos, such as aniridia and Lisch nodules associated with neurofibromatosis. IOP should be measured promptly within the first few minutes of anesthesia to avoid falsely low readings. Gonioscopy using a direct gonioscope may demonstrate significant findings, including anterior iris insertion onto the trabecular meshwork, vascular loops in the angle known as the "Loch Ness monster" phenomenon, and "Lister’s morning mist," characterized by fine, fluffy tissue on the peripheral iris.

Ophthalmoscopy may demonstrate optic disc cupping, which is notable for its potential reversibility with appropriate treatment in cases of primary congenital glaucoma. Ultrasound biomicroscopy is recommended when the cornea is opaque to evaluate anterior segment structures effectively. Consultation with clinical genetics may also be advised to assess for hereditary factors and guide further management.

Treatment / Management

The primary goal of buphthalmos treatment is to lower IOP to prevent progressive corneal opacification and glaucomatous optic atrophy, thus preserving existing vision.[14] The most definitive approach to treating buphthalmos is surgical, while medical management is used to control IOP and facilitate clearer visualization of the cornea during surgery.[15]

Medical Treatment

Pharmacological options for buphthalmos include topical β-blockers, carbonic anhydrase inhibitors, and prostaglandin analogs. As mentioned, these medications help manage IOP and can be essential in preparing the patient for surgical intervention.[16]

Surgical Treatment

Several surgical options are available for treating buphthalmos. Goniotomy involves creating openings in the trabecular meshwork to reduce resistance to aqueous outflow.[17] Trabeculotomy entails incising the trabecular meshwork by cannulating the Schlemm canal with a probe. Trabeculectomy is performed by removing a section of the trabecular meshwork and Schlemm canal under a partial thickness scleral flap, creating a fistula that drains aqueous humor into the subconjunctival space.[18] A combined trabeculotomy and trabeculectomy procedure involves the removal of a block of sclera after completing trabeculectomy.[19] Other options include glaucoma drainage implants and cyclodestructive procedures, which may be used in more complex cases.[20][21][20](A1)

Correcting refractive errors and managing amblyopia are important components of postoperative care. Lifelong IOP monitoring is necessary to ensure ongoing management and prevent future complications.

Differential Diagnosis

The following conditions can cause an abnormal appearance of the eye that may be mistaken for buphthalmos. A thorough eye examination is essential to rule out these other diseases.

  • Aniridia
  • Coat disease
  • Dysplasia of retina
  • Endophthalmitis
  • Inflammatory cyclitic membrane
  • Neurofibromatosis type 1
  • Persistent hyperplastic primary vitreous
  • Retinoblastoma
  • Sturge-Weber syndrome
  • Toxocariasis

The presence of these conditions does not exclude the possibility that the patient may have buphthalmos. Additionally, some of these conditions, such as aniridia, neurofibromatosis type 1, and Sturge-Weber syndrome, are associated with buphthalmos.

Staging

The staging of congenital glaucoma is based on the severity of the disease and clinical findings. In stage 1 (mild), IOP is slightly elevated, with minimal corneal edema and slight corneal enlargement. Stage 2 (moderate) is characterized by noticeable optic nerve cupping, moderate corneal edema with Haab striae, and a corneal diameter measuring 13 to 14 mm. Stage 3 (severe) involves advanced optic nerve damage with significant visual impairment, severe corneal edema and opacification, and a corneal diameter greater than 14 mm.[22]

Prognosis

The visual prognosis for a patient with buphthalmos due to congenital glaucoma that goes undiagnosed for many years is generally very poor. Vision loss due to congenital glaucoma is irreversible and severe. Early surgical intervention for these patients is associated with better visual outcomes.[23] If treated early, glaucomatous progression typically does not occur in the majority of cases within the 1st year of treatment. Many patients who receive early treatment maintain useful vision and remain visually unimpaired throughout their lives. However, nearly half of patients experience further progression later in life, emphasizing the importance of regular lifelong ophthalmic monitoring (see Image. Buphthalmos in an Adult).[24]

Complications

IOP elevation presents as buphthalmos in pediatric patients, with complications stemming from high IOP. The sequelae include glaucomatous optic neuropathy, corneal damage, amblyopia, and refractive errors. Early IOP reduction can help prevent these complications. However, amblyopia and refractive errors must be treated separately if they occur.[25] Corneal damage may be irreversible, potentially requiring surgical intervention in the future.[26]

Deterrence and Patient Education

Educating providers and parents about buphthalmos being a sign of congenital glaucoma is vital to preventing irreversible vision loss. One study found that 97% of the time, parents were the first to identify the signs of congenital glaucoma and refer the patient to a healthcare provider.[27] This finding highlights the importance of educating parents about ocular abnormalities. Parents should be educated that large eyes may be a sign of a serious ocular condition and that the child should be seen by an eye care specialist as soon as possible. Proper education for parents and providers covering early signs and symptoms of congenital glaucoma can prevent blindness from this disease.

Enhancing Healthcare Team Outcomes

An interprofessional approach is often required to manage buphthalmos. The interprofessional team may include ophthalmologists, optometrists, pediatricians, and other healthcare providers. The main treatment goal is to reduce IOP to prevent progressive corneal opacification and glaucomatous optic atrophy, thus preserving vision. The most definitive treatment of buphthalmos is surgical. Medical management is necessary to control IOP and clear the cornea for surgery.

The prognosis of buphthalmos has slightly improved over the years. Many children require low-vision aids and visual rehabilitation despite treatment.[28] Once considered a condition with a bleak prognosis, buphthalmos may now be managed reasonably well with modern surgical procedures. Early treatment and quality care coordination among different healthcare professionals can improve lifelong visual prognosis in patients with this disease.[29]

Media


(Click Image to Enlarge)
<p>Buphthalmos. The image&nbsp;shows an infant with right-sided buphthalmos.</p>

Buphthalmos. The image shows an infant with right-sided buphthalmos.

Michalgoback, Public Domain, via Wikimedia Commons


(Click Image to Enlarge)
<p>Buphthalmos with Bilateral Tearing and Light Sensitivity

Buphthalmos with Bilateral Tearing and Light Sensitivity. The image shows buphthalmos in a 9-month-old boy who presents with bilateral tearing and light sensitivity. Bilateral swelling of the globes is indicated by the enlargement of the corneas, with tears in the Descemet membrane and inferior corneal edema. The sclera shows a bluish appearance due to its thinning and the uveal tissue showing through. The corneal diameter is 13 mm (normal is 10.5 mm in a child this age). The intraocular pressures are 35 mm Hg in the right and 38 mm Hg in the left.

Contributed by BCK Patel, MD, FRCS


(Click Image to Enlarge)
<p>Buphthalmos in an Adult

Buphthalmos in an Adult. This patient had buphthalmos as a child, which was inadequately treated. Enlargement of the globes and opacification of the corneas are seen.

Contributed by BCK Patel, MD, FRCS

References


[1]

Beck AD. Diagnosis and management of pediatric glaucoma. Ophthalmology clinics of North America. 2001 Sep:14(3):501-12     [PubMed PMID: 11705150]


[2]

Kaur K, Zeppieri M, Gurnani B. Primary Congenital Glaucoma. StatPearls. 2025 Jan:():     [PubMed PMID: 34662067]


[3]

Vasiliou V, Gonzalez FJ. Role of CYP1B1 in glaucoma. Annual review of pharmacology and toxicology. 2008:48():333-58     [PubMed PMID: 17914928]


[4]

Chien YH, Huang HP, Hwu WL, Chien YH, Chang TC, Lee NC. Eye anomalies and neurological manifestations in patients with PAX6 mutations. Molecular vision. 2009 Oct 22:15():2139-45     [PubMed PMID: 19898691]


[5]

Javaid U, Ali MH, Jamal S, Butt NH. Pathophysiology, diagnosis, and management of glaucoma associated with Sturge-Weber syndrome. International ophthalmology. 2018 Feb:38(1):409-416. doi: 10.1007/s10792-016-0412-3. Epub 2017 Jan 7     [PubMed PMID: 28064423]


[6]

Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in neurofibromatosis type 1. Survey of ophthalmology. 2018 Jul-Aug:63(4):518-533. doi: 10.1016/j.survophthal.2017.10.007. Epub 2017 Nov 16     [PubMed PMID: 29080631]

Level 3 (low-level) evidence

[7]

Samant M, Chauhan BK, Lathrop KL, Nischal KK. Congenital aniridia: etiology, manifestations and management. Expert review of ophthalmology. 2016:11(2):135-144. doi: 10.1586/17469899.2016.1152182. Epub 2016 Mar 9     [PubMed PMID: 30100922]


[8]

Aziz A, Fakhoury O, Matonti F, Pieri E, Denis D. [Epidemiology and clinical characteristics of primary congenital glaucoma]. Journal francais d'ophtalmologie. 2015 Dec:38(10):960-6. doi: 10.1016/j.jfo.2015.04.018. Epub 2015 Oct 29     [PubMed PMID: 26522891]


[9]

Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Abu-Amero KK, Edward DP. Primary Congenital Glaucoma. GeneReviews(®). 1993:():     [PubMed PMID: 20301314]


[10]

Jacobson A, Bohnsack BL. Factors and outcomes associated with corneal edema and Haabs striae in primary congenital glaucoma. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2024 Apr:28(2):103860. doi: 10.1016/j.jaapos.2024.103860. Epub 2024 Mar 3     [PubMed PMID: 38442850]


[11]

Alves M, Malki LT, Rocha EM. Buphthalmos development in adult: case report. Arquivos brasileiros de oftalmologia. 2012 Oct:75(5):361-2     [PubMed PMID: 23471335]

Level 3 (low-level) evidence

[12]

Vasileiadis GT, Frangouli O. Unilateral congenital buphthalmos. BMJ case reports. 2015 Jun 3:2015():. doi: 10.1136/bcr-2015-210979. Epub 2015 Jun 3     [PubMed PMID: 26040832]

Level 3 (low-level) evidence

[13]

Mahelková G, Filous A, Odehnal M, Cendelín J. Corneal changes assessed using confocal microscopy in patients with unilateral buphthalmos. Investigative ophthalmology & visual science. 2013 Jun 10:54(6):4048-53. doi: 10.1167/iovs.12-11165. Epub 2013 Jun 10     [PubMed PMID: 23696604]


[14]

Aponte EP, Diehl N, Mohney BG. Medical and surgical outcomes in childhood glaucoma: a population-based study. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2011 Jun:15(3):263-7. doi: 10.1016/j.jaapos.2011.02.015. Epub 2011 Jun 11     [PubMed PMID: 21652244]


[15]

Gusson E, Chemello F, Longo R, Franzolin E, Vesentini R, Verlato G, Marchini G. Primary congenital glaucoma surgery: outcomes and visual function. International ophthalmology. 2021 Nov:41(11):3861-3867. doi: 10.1007/s10792-021-01957-0. Epub 2021 Jul 23     [PubMed PMID: 34297306]


[16]

Yu Chan JY, Choy BN, Ng AL, Shum JW. Review on the Management of Primary Congenital Glaucoma. Journal of current glaucoma practice. 2015 Sep-Dec:9(3):92-9. doi: 10.5005/jp-journals-10008-1192. Epub 2016 Feb 2     [PubMed PMID: 26997844]


[17]

El Sayed Y, Esmael A, Mettias N, El Sanabary Z, Gawdat G. Factors influencing the outcome of goniotomy and trabeculotomy in primary congenital glaucoma. The British journal of ophthalmology. 2021 Sep:105(9):1250-1255. doi: 10.1136/bjophthalmol-2018-313387. Epub 2019 Mar 7     [PubMed PMID: 30846492]


[18]

Khalil DH, Abdelhakim MA. Primary trabeculotomy compared to combined trabeculectomy-trabeculotomy in congenital glaucoma: 3-year study. Acta ophthalmologica. 2016 Nov:94(7):e550-e554. doi: 10.1111/aos.13018. Epub 2016 Apr 1     [PubMed PMID: 27037905]


[19]

Elder MJ. Combined trabeculotomy-trabeculectomy compared with primary trabeculectomy for congenital glaucoma. The British journal of ophthalmology. 1994 Oct:78(10):745-8     [PubMed PMID: 7803349]


[20]

Badawi AH, Al Owaifeer AM, Mofti A, Al-Shahwan S, Al Jadaan I, Malik R. Comparison of the Ahmed and Baerveldt Glaucoma Drainage Implants in the Treatment of Primary Congenital Glaucoma. Journal of pediatric ophthalmology and strabismus. 2023 Nov-Dec:60(6):448-454. doi: 10.3928/01913913-20230119-02. Epub 2023 Feb 21     [PubMed PMID: 36803242]


[21]

Elhusseiny AM, Hassan AK, Elsaman AS, Azhari JO, VanderVeen DK, Abdelnaem S, Pakravan M, Chang TC, Khodeiry MM, Khouri AS, Sayed MS, Lee RK, Sallam AB. Continuous Wave Transscleral Cyclophotocoagulation and Endoscopic Cyclophotocoagulation in Childhood Glaucoma: A Meta-Analysis. Journal of glaucoma. 2024 Jun 1:33(6):456-463. doi: 10.1097/IJG.0000000000002365. Epub 2024 Jan 26     [PubMed PMID: 38506746]

Level 1 (high-level) evidence

[22]

Badawi AH, Al-Muhaylib AA, Al Owaifeer AM, Al-Essa RS, Al-Shahwan SA. Primary congenital glaucoma: An updated review. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2019 Oct-Dec:33(4):382-388. doi: 10.1016/j.sjopt.2019.10.002. Epub 2019 Nov 7     [PubMed PMID: 31920449]


[23]

Wagner FM, Schuster AK, Grehn F, Urbanek L, Pfeiffer N, Stingl JV, Hoffmann EM. Twenty-Years of Experience in Childhood Glaucoma Surgery. Journal of clinical medicine. 2021 Dec 8:10(24):. doi: 10.3390/jcm10245720. Epub 2021 Dec 8     [PubMed PMID: 34945031]


[24]

de Silva DJ, Khaw PT, Brookes JL. Long-term outcome of primary congenital glaucoma. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2011 Apr:15(2):148-52. doi: 10.1016/j.jaapos.2010.11.025. Epub     [PubMed PMID: 21596293]


[25]

Chaudhary RS, Gupta A, Sharma A, Gupta S, Sofi RA, Sundar D, Sihota R, Somarajan BI, Singh A, Sangwan R, Gupta V. Long-term functional outcomes of different subtypes of primary congenital glaucoma. The British journal of ophthalmology. 2020 Sep:104(9):1288-1292. doi: 10.1136/bjophthalmol-2019-315131. Epub 2019 Dec 23     [PubMed PMID: 31871047]


[26]

Toker E, Seitz B, Langenbucher A, Dietrich T, Naumann GO. Penetrating keratoplasty for endothelial decompensation in eyes with buphthalmos. Cornea. 2003 Apr:22(3):198-204     [PubMed PMID: 12658082]

Level 2 (mid-level) evidence

[27]

Leite A, Rolim-de-Moura C. Referral reasons for evaluating childhood glaucoma in a tertiary service. Arquivos brasileiros de oftalmologia. 2022 Sep-Oct:85(5):465-471. doi: 10.5935/0004-2749.20220067. Epub     [PubMed PMID: 34852063]


[28]

Zagora SL, Funnell CL, Martin FJ, Smith JE, Hing S, Billson FA, Veillard AS, Jamieson RV, Grigg JR. Primary congenital glaucoma outcomes: lessons from 23 years of follow-up. American journal of ophthalmology. 2015 Apr:159(4):788-96. doi: 10.1016/j.ajo.2015.01.019. Epub 2015 Jan 26     [PubMed PMID: 25634533]

Level 2 (mid-level) evidence

[29]

Yassin SA. Long-Term Visual Outcomes in Children with Primary Congenital Glaucoma. European journal of ophthalmology. 2017 Nov 8:27(6):705-710. doi: 10.5301/ejo.5000976. Epub     [PubMed PMID: 28430330]